Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Long-Term Deferred Tax (2020)

Tango Therapeutics has reported Long-Term Deferred Tax over the past 1 years, most recently at $31262.0 for Q4 2020.

  • Quarterly results put Long-Term Deferred Tax at $31262.0 for Q4 2020, changed N/A from a year ago — trailing twelve months through Dec 2020 was $31262.0 (changed N/A YoY), and the annual figure for FY2020 was $31262.0, changed.
  • Long-Term Deferred Tax for Q4 2020 was $31262.0 at Tango Therapeutics.
  • Over the last five years, Long-Term Deferred Tax for TNGX hit a ceiling of $31262.0 in Q4 2020 and a floor of $31262.0 in Q4 2020.